” Initiatives with the greatest impact often cut across institutional silos in colleges, departments, and programs, yielding measurable community health benefits. Community leaders also facilitated

collaboration by enlisting University of New Mexico educational and clinical resources to better respond to their local priorities. Early progress in New Mexico’s health outcomes measures and state health ranking is a promising sign of movement toward Vision 2020. (C) 2015 American Journal of Preventive Medicine”
“We designed and synthesized novel PPAR delta antagonists based Cilengitide cell line on the crystal structure of the PPAR delta full agonist TIPP-204 bound to the PPAR delta ligand-binding domain, in combination with our nuclear receptor helix 12 folding modification hypothesis.

Representative compound 3a exhibits PPAR delta-preferential antagonistic activity. (C) 2009 Salubrinal mouse Elsevier Ltd. All rights reserved.”
“Among the “omics”, glycomics is one of the most complex fields and needs complementary strategies of analysis to decipher the “glycan dictionary”. As an alternative method, which has developed since the beginning of the 21st century, lectin array technology could generate relevant information related to glycan motifs, accessibility and a number of other valuable insights from molecules (purified and non-purified) or cells. Based on a cell line model, this study deals with the key parameters that influence the whole cell surface glycan interaction with lectin arrays and the consequences on the interpretation and reliability of the results. The comparison between the adherent and suspension forms of Chinese Hamster Ovary (CHO) cells, showed respective glycan signatures, which could be inhibited specifically

by neoglycoproteins. The modifications of the respective glycan signatures were also revealed Ruboxistaurin nmr according to the detachment modes and cell growth conditions. Finally the power of lectin array technology was highlighted by the possibility of selecting and characterizing a specific clone from the mother cell line, based on the slight difference determination in the respective glycan signatures.”
“MicroRNAs (miRNAs) are known to be involved in carcinogenesis and tumor progression in hepatocellular carcinoma (HCC). Recently, microRNA-7 (miR-7) has been proven to play a substantial role in glioblastoma and breast cancer, but its functions in the context of HCC remain unknown. Here, we demonstrate that miR-7 inhibits HCC cell growth and metastasis invitro and in vivo. We first screened and identified a novel miR-7 target, phosphoinositide 3-kinase catalytic subunit delta (PIK3CD). Overexpression of miR-7 would specifically and markedly down-regulate its expression.